Singapore markets closed
  • Straits Times Index

    3,157.97
    -4.53 (-0.14%)
     
  • Nikkei

    28,948.73
    -9.83 (-0.03%)
     
  • Hang Seng

    28,842.13
    +103.25 (+0.36%)
     
  • FTSE 100

    7,134.06
    +45.88 (+0.65%)
     
  • BTC-USD

    35,752.96
    -1,440.54 (-3.87%)
     
  • CMC Crypto 200

    924.19
    -17.62 (-1.87%)
     
  • S&P 500

    4,247.44
    +8.26 (+0.19%)
     
  • Dow

    34,479.60
    +13.36 (+0.04%)
     
  • Nasdaq

    14,069.42
    +49.09 (+0.35%)
     
  • Gold

    1,879.50
    -16.90 (-0.89%)
     
  • Crude Oil

    70.78
    +0.49 (+0.70%)
     
  • 10-Yr Bond

    1.4620
    +0.0030 (+0.21%)
     
  • FTSE Bursa Malaysia

    1,575.16
    -4.74 (-0.30%)
     
  • Jakarta Composite Index

    6,095.50
    -12.04 (-0.20%)
     
  • PSE Index

    6,907.79
    +32.08 (+0.47%)
     

Global Chronic Pain Epidemiology and Patient Flow Analysis Report 2021: Chronic Pain Prevalence, Diagnosed, and Drug-Treated Patients

·2-min read

Dublin, May 13, 2021 (GLOBE NEWSWIRE) -- The "Global Chronic Pain Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.

Global Chronic Pain Epidemiology and Patient Flow Analysis - 2021, provides Chronic Pain epidemiology, demographics, and patient flow. The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.

The research provides population data to characterize Chronic Pain patients, history of the disease at the population level (Chronic Pain prevalence, Chronic Pain incidence) and at the clinical level (from diagnosis to treated patients). It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.

Research scope:

  • Chronic Pain patient flow: Chronic Pain prevalence, diagnosed, and drug-treated patients

  • Countries: US, Germany, France, Italy, Spain, UK, Japan, G7 Countries

  • Demographics: Chronic Pain patients by age group, gender

  • Forecast: Chronic Pain epidemiology forecast to 2035

The data from this research will help executives:

  • Establish basis for Chronic Pain market sizing, assessing market potential, and developing drug forecast models

  • Identify Chronic Pain patients segments through age groups, gender, and disease sub-types

  • Develop Chronic Pain population-based health management frameworks

  • Evaluate Chronic Pain market opportunities, identify target patient population

  • Align marketing decisions with the Chronic Pain target population

  • Communicate leadership and health authorities about your Chronic Pain target patient population

Key Topics Covered:

1. Research Methodology

2. Chronic Pain Patients Definition

3. US Chronic Pain Epidemiology and Patient Flow

4. Germany Chronic Pain Epidemiology and Patient Flow

5. France Chronic Pain Epidemiology and Patient Flow

6. Italy Chronic Pain Epidemiology and Patient Flow

7. Spain Chronic Pain Epidemiology and Patient Flow

8. UK Chronic Pain Epidemiology and Patient Flow

9. Europe Chronic Pain Epidemiology and Patient Flow

10. Japan Chronic Pain Epidemiology and Patient Flow

11. Global Chronic Pain Epidemiology and Patient Flow

For more information about this report visit https://www.researchandmarkets.com/r/cckrdq

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900